997 / 1224
MESSAGE TO TAKE HOME
•
SBRT offers high local control in selected patients with primary
liver tumors
•
SBRT can be delivered as a definitive treatment but also as a
pre-transplant therapy
•
Toxicity is acceptable in most studies, however patients with
advanced cirrhosis have a higher risk of toxicity
•
Randomized trials are needed to define the role of SBRT in the
treatment of primary liver tumors